A Medtech Insight analysis of US Senate and House lobbying disclosure reports filed by cardiac device manufacturers and their lobbying firms for the first quarter of 2020 shows companies would like to move the legislative needle on eight core issues, with most pushing lawmakers for higher Centers for Medicare and Medicaid Services (CMS) reimbursements and better COVID-19 solutions.
For this review, Medtech Insight examined quarterly lobbying disclosure reports filed by cardiac device makers, with a focus on the issues and dollars spent. We also looked into the professional...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?